Project Grant HT94252510756
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
The Regents of the University of California, San Francisco (UCSF) has been awarded a $1,437,598 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, effective September 1, 2024 through August 31, 2027, will fund the "TRANSFORMING RESEARCH AND CLINICAL KNOWLEDGE IN TRAUMATIC BRAIN INJURY: CONCUSSION OUTCOME AND RECOVERY PREDICTION SCORE (TRACK-TBI: CORPS)" project. This research initiative aims...
This federal Project Grant award of $2,433,748.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "DECISION SUPPORT TOOLS ADDRESSING TRAUMATIC BRAIN INJURY IN BRIDGE (STAT-BRIDGE)" research project. The grant was awarded on June 1, 2025 to The Regents of the University of California, San Francisco, a prominent academic medical center and research institution, with a performance period through May 31, 2029. The...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $3,766,416.00 to The Regents of the University of California, San Francisco (UCSF) to conduct advanced biomedical research on expansile duraplasty for the treatment of acute traumatic spinal cord injury. The award has a performance period from July 1, 2025 to June 30, 2029. As a leading academic medical center and research institution, UCSF will leverage...
The federal Project Grant award for "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $860,998 award to The Regents of the University of California, San Francisco (UCSF) supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project will investigate...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $328,000.00 in funding to The Regents of the University of California, San Francisco (UCSF) to investigate intracalvarial drug delivery strategies into skull bone marrow to create an antitumoral myeloid cell immune response to glioblastoma. The award period is from July 1, 2025 to June 30, 2027. As a leading academic medical center and research...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,594,419.00 to The Regents of the University of California, San Francisco (UCSF) to conduct radiopathomic mapping of tumor burden for personalized management of IDH-mutant glioma. The award period runs from September 1, 2025 to August 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in translational...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $574,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on "Targeting and Imaging Vitamin B5 Metabolism in Diffuse Midline Gliomas". The award period runs from Sep 1, 2025 to Aug 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in biomedical research,...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...